FDA Grants Accelerated Approval To New Alzheimer’s Drug
The U.S. Food and Drug Administration (FDA) granted accelerated approval for a new drug designed to treat Alzheimer’s on Friday.The drug is Leqembi, which was created by Japanese pharmaceutical company Eisai, which will work with Biogen…